Publication: Ectodysplasin A2 receptor signaling in skeletal muscle pathophysiology
dc.contributor.department | Department of Molecular Biology and Genetics | |
dc.contributor.department | Graduate School of Sciences and Engineering | |
dc.contributor.kuauthor | Kır, Serkan | |
dc.contributor.kuauthor | Özen, Sevgi Döndü | |
dc.contributor.schoolcollegeinstitute | College of Sciences | |
dc.contributor.schoolcollegeinstitute | GRADUATE SCHOOL OF SCIENCES AND ENGINEERING | |
dc.date.accessioned | 2024-12-29T09:39:55Z | |
dc.date.issued | 2024 | |
dc.description.abstract | Skeletal muscle is essential in generating mechanical force and regulating energy metabolism and body temperature. Pathologies associated with muscle tissue often lead to impaired physical activity and imbalanced metabolism. Recently, ectodysplasin A2 receptor (EDA2R) signaling has been shown to promote muscle loss and glucose intolerance. Upregulated EDA2R expression in muscle tissue was associated with aging, denervation, cancer cachexia, and muscular dystrophies. Here, we describe the roles of EDA2R signaling in muscle pathophysiology, including muscle atrophy, insulin resistance, and aging-related sarcopenia. We also discuss the EDA2R pathway, which involves EDA-A2 as the ligand and nuclear factor (NF)κB-inducing kinase (NIK) as a downstream mediator, and the therapeutic potential of targeting these proteins in the treatment of muscle wasting and metabolic dysfunction. © 2024 Elsevier Ltd | |
dc.description.indexedby | WOS | |
dc.description.indexedby | Scopus | |
dc.description.indexedby | PubMed | |
dc.description.issue | 5 | |
dc.description.publisherscope | International | |
dc.description.sponsoredbyTubitakEu | TÜBİTAK | |
dc.description.sponsorship | This work was supported by the European Molecular Biology Organization (EMBO) installation grant (# 4162 ) and the Scientific and Technological Research Council of Turkiye (TUBITAK) grants ( 118Z167 , 122Z163 ) to S. Kir. | |
dc.description.volume | 30 | |
dc.identifier.doi | 10.1016/j.molmed.2024.02.002 | |
dc.identifier.eissn | 1471-499X | |
dc.identifier.issn | 1471-4914 | |
dc.identifier.quartile | Q1 | |
dc.identifier.scopus | 2-s2.0-85186663470 | |
dc.identifier.uri | https://doi.org/10.1016/j.molmed.2024.02.002 | |
dc.identifier.uri | https://hdl.handle.net/20.500.14288/23164 | |
dc.identifier.wos | 1240297900001 | |
dc.keywords | Aging-related sarcopenia | |
dc.keywords | Ectodysplasin A2 receptor signaling | |
dc.keywords | Insulin resistance in muscle | |
dc.keywords | NFκB-inducing kinase | |
dc.keywords | Skeletal muscle atrophy | |
dc.language.iso | eng | |
dc.publisher | Elsevier Ltd | |
dc.relation.grantno | European Molecular Biology Organization, EMBO, (4162) | |
dc.relation.grantno | Türkiye Bilimsel ve Teknolojik Araştırma Kurumu, TÜBİTAK, (118Z167, 122Z163) | |
dc.relation.ispartof | Trends in Molecular Medicine | |
dc.subject | Biochemistry and molecular biology | |
dc.subject | Cell biology | |
dc.subject | Medicine, research and experimental | |
dc.title | Ectodysplasin A2 receptor signaling in skeletal muscle pathophysiology | |
dc.type | Review | |
dspace.entity.type | Publication | |
local.contributor.kuauthor | Özen, Sevgi Döndü | |
local.contributor.kuauthor | Kır, Serkan | |
local.publication.orgunit1 | College of Sciences | |
local.publication.orgunit1 | GRADUATE SCHOOL OF SCIENCES AND ENGINEERING | |
local.publication.orgunit2 | Department of Molecular Biology and Genetics | |
local.publication.orgunit2 | Graduate School of Sciences and Engineering | |
relation.isOrgUnitOfPublication | aee2d329-aabe-4b58-ba67-09dbf8575547 | |
relation.isOrgUnitOfPublication | 3fc31c89-e803-4eb1-af6b-6258bc42c3d8 | |
relation.isOrgUnitOfPublication.latestForDiscovery | aee2d329-aabe-4b58-ba67-09dbf8575547 | |
relation.isParentOrgUnitOfPublication | af0395b0-7219-4165-a909-7016fa30932d | |
relation.isParentOrgUnitOfPublication | 434c9663-2b11-4e66-9399-c863e2ebae43 | |
relation.isParentOrgUnitOfPublication.latestForDiscovery | af0395b0-7219-4165-a909-7016fa30932d |